Michigan Medicine Fumbling the Ball, What is it’s Game Plan?

What is the Screening Protocol for Cancer Infusion Therapy at Rogel Cancer Center?

Before chemotherapy is administered, healthcare providers follow a rigorous multi-step screening and assessment protocol to ensure the patient’s body can safely handle the treatment. This process includes baseline medical evaluations, specific lab tests, and safety verifications.

Mcdonald’s Screening Protocol to provide Service

McDonald’s frequently displays “No Shirt, No Shoes, No Service” signs, a common, lawful policy used by businesses to ensure customer safety and maintain service standards. These signs are largely aimed at preventing safety hazards, such as slip-and-fall risks for customers walking in wet from nearby pools or protecting customers from hazards.

Michigan Medicine Oncology Department has no Clinical Medicine Protocol to Screen Patients with Upper Respiratory Tract Infectios

Reporting Concerns to Michigan Medicine Patient Relations and Clinical Risk Program

Sent: Tuesday, April 28, 2026 at 12:16:28 PM EDT

Subject: [SECURE] Patient Relations Concern

You are receiving this secure, encrypted email message because it may contain sensitive information. If you have concerns about the validity of this message, contact the sender directly and ensure the email address is a known @med.umich.edu email address.

Secured by Proofpoint Encryption, Copyright © 2009-2025 Proofpoint, Inc. All rights reserved.

I want to bring to your attention that a patient received corticosteroid therapy (Tablet Dexamethasone twice daily on Monday, April 06, Tuesday, April 07, and on Wednesday, April 08, while she was experiencing an Upper Respiratory Tract Infection. This steroid therapy can easily mask symptoms like fever while aggravating the severity of the infection.

Taking dexamethasone tablets during an upper respiratory tract infection (URTI) poses significant risks due to its immunosuppressant nature, which can worsen or mask infections. It may delay viral clearance, promote bacterial superinfections, and increase risks for serious complications like pneumonia or secondary fungal infections.

Key Risks of Dexamethasone with URTIs:

• Increased Infection Severity: Dexamethasone lowers your immune system, making it easier to catch infections and harder for your body to fight existing ones. It can cause infections to become more severe or fatal.
• Masking Symptoms: By suppressing inflammation, dexamethasone can mask signs of infection, such as fever, causing a delay in necessary medical treatment.
• Secondary/Reactivated Infections: It can increase the risk of developing secondary infections or causing latent infections (like tuberculosis or hepatitis B) to become active again.
• Increased Viral Load: Evidence suggests that corticosteroids like dexamethasone can delay the clearance of viruses from the body.
• Respiratory Complications: The use of dexamethasone in patients with viral infections can be associated with increased mortality and, in some cases, exacerbation of respiratory conditions.
• Systemic Side Effects: Even short-term use can lead to side effects such as high blood pressure, hyperglycemia (high blood sugar), and fluid retention. This patient reported to the Clinic with hyperglycemia on the day of Infusion therapy.

Re: [SECURE] Patient Relations Concern

• From Patient Relations: Apr 28Apr 28 at 1:20 PM
  • What specifically led you to believe the screening protocol is “dangerously inadequate” and “medically unethical”?Was there a particular date, visit, or appointment when this occurred?When you say the patient was “deliberately exposed to the consequences of a viral infection,” what do you mean? For example, was the concern about possible exposure to others who were ill, or about proceeding with treatment despite symptoms?Regarding the persistent, recurrent cough, when was this ignored by caregivers?
•  1. It is medically unethical to administer drugs without fully disclosing the side effects of the medications. The patient must be duly informed about the risks involved and the patient must get an opportunity to make an informed choice about the therapeutic intervention. The Hospital has billed the patient $400.00 to impart education to learn about the drugs and their adverse effects which could be life threatening. The educator provided by the Hospital has the fundamental duty to assess the risks that of direct concern to the particular, specific patient. The Screening is put in place to avoid negative outcomes for the patient. The Screening Protocol must determine the medical fitness of the patient to receive the therapy planned. Patient’s life is endangered by the administration of Chemotherapy while the patient is infected by an infectious agent and exhibiting clear symptoms of an active infection that produces charateristic symptoms.
  2. This unfortunate incident took place on Tuesday, April 7 at the University Hospital and the event is recorded in the patient’s medical documents and the aftercare summary notes available on the patient portal.
  3. Patient is placed at the extreme risk of losing life on account of administering a therapeutic agent while immunocompromised. The patient’s age and her medical condition are known risk factors and the presence of an active infection is a known contraindications to the planned infusion therapy on April 07. The treatment plan must not proceed even if the patient with symptomatic Upper Respiratory Tract infection has come to the clinic.
  4. On April 07, at the University Hospital, the Physician Assistant deliberately ignored the concerns shared by the patient, her son and her spouse about Dry persistent Cough. The educator gave false assurances by dismissing the concern and suggested that viral infections in the community cause these problems like cough and failed to mention the risk of Pneumonia that can cause respiratory failure and death.

The patient talked to Patient Relations on the phone on April 28. 2026 to confirm that she has concerns to share about her Office Visit with PA-C on Tuesday, April 07, 2026, 2.40 P.M., at Thoracic Oncology Clinic, University of Michigan Health Infusion Area, Rogel Cancer Center for assessment of her medical fitness prior to Infusion Therapy prescribed by Michigan Medicine Oncologist. The Medical Negligence of this caregiver directly resulted in patient’s admission to University Hospital on April 12, 2026 and she remains in the Hospital  on this day, Wednesday, April 29, 2026 suffering from the direct consequences of infection with Human Metapneumovirus (hMPV) and lost the benefit of receiving the planned palliative care scheduled for April 28, 2026. The evidence of this infection was apparent on Tuesday, April 07, 2026 during the above mentioned Office Visit.

Medical negligence is a legal concept defining when a healthcare professional deviates from the accepted standard of care, causing injury or death to a patient. It occurs when a provider acts—or fails to act—in a way a reasonably competent professional would not, often labeled as medical malpractice. Key elements include duty, breach, causation, and damages. 

• Failure to Obtain Informed Consent: Failing to inform a patient of the risks of a procedure, leading to an injury they would have otherwise avoided.
• World Class Medical Care refers to Stringent Quality Standards: Adherence to superior clinical guidelines that often result in significantly lower readmission rates compared to national averages.
• Screening Protocol for giving Cancer Chemotherapy to Patients: Before chemotherapy is administered, healthcare providers follow a rigorous multi-step screening and assessment protocol to ensure the patient’s body can safely handle the treatment. This process includes baseline medical evaluations, specific lab tests, and safety verifications.